Furthermore, it would be interesting to study more specifically the anti-ENO1 antibodies and their potentially protective role because some studies on the prevention and treatment of autoimmune diseases have shown the effectiveness of protocols using different types of antibodies, either bispecific or multimers, including some that have been assessed in the CIA mouse model [32–35]. Here, ENO1 is linked to autoimmune disease.